{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:50:15Z","timestamp":1792227015174,"version":"4.4.0"},"reference-count":9,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1188\/20.cjon.561-565","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:26:09Z","timestamp":1600428369000},"page":"561-565","source":"Crossref","is-referenced-by-count":11,"title":["Skin Toxicity: Clinical Summary of the ONS Guidelines\u2122 for Cancer Treatment\u2013Related Skin Toxicity"],"prefix":"10.1188","volume":"24","author":[{"given":"Kathleen","family":"Wiley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ebanks Jr.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Strelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Ciccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Belum, V.R., de Barros Silva, G., Laloni, M.T., Ciccolini, K., Goldfarb, S.B., Norton, L., . . . Lacouture, M.E. (2016). Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia. Breast Cancer Research and Treatment, 157(2), 395\u2013400. https:\/\/doi.org\/10.1007\/s10549-016-3799-7","DOI":"10.1007\/s10549-016-3799-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"De Tursi, M., Zilli, M., Carella, C., Auriemma, M., Lisco, M.N., Di Nicola, M., . . . Amerio, P. (2017). Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: A new tool for more accurate comprehension of quality of life impacts. OncoTargets and Therapy, 10, 3007\u20133015. https:\/\/doi.org\/10.2147\/OTT.S127795","DOI":"10.2147\/OTT.S127795"},{"key":"3","doi-asserted-by":"crossref","unstructured":"De Wit, M., Boers-Doets, C.B., Saettini, A., Vermeersch, K., de Juan, C.R., Ouwerkerk, J., . . . Cremolini, C. (2014). Prevention and management of adverse events related to regorafenib. Supportive Care in Cancer, 22(3), 837\u2013846. https:\/\/doi.org\/10.1007\/s00520-013-2085-z","DOI":"10.1007\/s00520-013-2085-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., . . . Sch\u00fcnemann, H.J. (2011). GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology, 64(4), 383\u2013394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Lacouture, M.E., Anadkat, M.J., Bensadoun, R.-J., Bryce, J., Chan, A., Epstein, J.B., . . . Murphy, B.A. (2011). Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Supportive Care in Cancer, 19(8), 1079\u20131095. https:\/\/doi.org\/10.1007\/s00520-011-1197-6","DOI":"10.1007\/s00520-011-1197-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Nikolaou, V., Syrigos, K., & Saif, M.W. (2016). Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opinion on Drug Safety, 15(12), 1625\u20131633. https:\/\/doi.org\/10.1080\/14740338.2016.1238067","DOI":"10.1080\/14740338.2016.1238067"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Rossi, A., Fortuna, M.C., Caro, G., Pranteda, G., Garelli, V., Pompili, U., & Carlesimo, M. (2017). Chemotherapy-induced alopecia management: Clinical experience and practical advice. Journal of Cosmetic Dermatology, 16(4), 537\u2013541. https:\/\/doi.org\/10.1111\/jocd.12308","DOI":"10.1111\/jocd.12308"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Salzmann, M., Marm\u00e9, F., & Hassel, J.C. (2019). Prophylaxis and management of skin toxicities. Breast Care, 14(2), 72\u201377. https:\/\/doi.org\/10.1159\/000497232","DOI":"10.1159\/000497232"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Williams, L.A., Ginex, P.K., Ebanks, G., Ganstwig, K., Ciccolini, K., Kwong, B.Y., . . . Morgan, R.L. (2020). ONS Guidelines\u2122 for cancer treatment\u2013related skin toxicity. Oncology Nursing Forum, 47(5), 539\u2013556. https:\/\/doi.org\/10.1188\/20.ONF.539-556","DOI":"10.1188\/20.ONF.539-556"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/24\/5\/skin-toxicity-clinical-summary-ons-guidelines-cancer-treatment-related-skin-toxicity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:50:03Z","timestamp":1763754603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/24\/5\/skin-toxicity-clinical-summary-ons-guidelinestm-cancer-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1188\/20.cjon.561-565","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}